Skip to content

Hemodynamic Effects of Continuous Intravenous Infusion S(+)-ketamine in Septic Shock Patients with Mechanical Ventilation: a Randomized, Controlled, Single-Center Clinical Study

Hemodynamic Effects of Continuous Intravenous Infusion S(+)-ketamine in Septic Shock Patients with Mechanical Ventilation: a Randomized, Controlled, Single-Center Clinical Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058199
Enrollment
Unknown
Registered
2022-04-01
Start date
2022-03-21
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock

Interventions

S(+)-ketamine group:Analgesia by S(+)-ketamine in 72H after admission
Remifentanil group:Analgesia by remifentanil in 72H after admission

Sponsors

Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age: >= 18 years old; 2. Patients diagnosis of septic shock: comply with the criteria of septic shock developed by SCCM/ESICM in 2016; 3. Patients with invasive mechanical ventilation, and the time is expected to more than 72 h; 4. Family members signed informed consent.

Exclusion criteria

Exclusion criteria: 1. A history of mental illness or cerebrovascular accident (cerebral hemorrhage or cerebral infarction) or brain injury during three months(including this time); 2. Pregnant women; 3. Contraindicate to S(+)-ketamine as the following: (1) Allergic to S(+)-ketamine and its accessories; (2) Confirmed but uncontrolled coronary heart disease; (3) Poorly controlled or uncontrolled hypertension (systolic/diastolic blood pressure more than 180/100 mmHg at rest); (4) Preeclampsia and eclampsia; (5) No treatment or inadequate treatment in patients with hyperthyroidism; (6) Aneurysm(rupture risk when hypertension); (7) Ophthalmologic operation(risk of elevated intraocular pressure); (8) Need of hysteranesis(uterine torn, uterine rupture, umbilical cord prolapse,etc); 4. Allergic to propofol and hyperlipidemia pancreatitis (triglycerides>11.3mmol/L).

Design outcomes

Primary

MeasureTime frame
Dose of norepinephrine;

Secondary

MeasureTime frame
Dose of sedative and analgesics;Hemodynamic parameters;Mechanical ventilation time;ICU length of stay;Incidence of abnormal electroencephalogram;Cognitive function;Prognosis;Function of organs;

Countries

China

Contacts

Public ContactLijun Liu

Second Affiliated Hospital of Soochow University

liulijun@suda.edu.cn+86 0512-67783628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026